-
公开(公告)号:US06924309B2
公开(公告)日:2005-08-02
申请号:US10100490
申请日:2002-03-18
IPC分类号: A61K8/30 , A61K8/36 , A61K8/40 , A61K8/46 , A61K31/04 , A61K31/10 , A61K31/19 , A61K31/20 , A61K31/202 , A61K31/21 , A61K31/335 , A61P1/04 , A61P1/18 , A61P3/10 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/02 , A61P11/06 , A61P17/00 , A61P17/06 , A61P25/00 , A61P29/00 , A61P31/00 , A61P33/06 , A61P35/00 , A61P37/02 , A61P37/06 , A61P37/08 , A61P39/06 , A61P43/00 , C07C17/16 , C07C45/30 , C07C205/02 , C07C205/03 , C07C205/14 , C07C205/15 , C07C205/50 , C07C205/51 , C07C317/44 , C07C321/14 , C07C321/18 , C07C323/52 , C07C409/40 , A01N37/00 , C07C229/00 , C07C207/00 , C07C205/00
CPC分类号: C07C409/40 , A61K31/19 , A61K31/20 , A61K31/202 , A61K31/21 , A61K31/335 , A61K45/06 , C07C17/16 , C07C45/30 , C07C205/02 , C07C205/03 , C07C205/14 , C07C205/15 , C07C205/50 , C07C205/51 , C07C317/44 , C07C323/52 , Y02A50/411 , C07C19/075 , C07C21/14 , C07C47/02 , C07C47/21 , A61K2300/00
摘要: The present invention relates to compounds of the general formula: NO2-A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH2)n(COOH)m in which n is an integer from 0 to 2 and m is an integer from 0 to 2; or of general formula (I), wherein A′ is a saturated or unsaturated hydrocarbon chain of 9-26 carbon atoms, X is oxygen or is absent and B′ is (CH2)j(COOH)k in which j is an integer from 1 to 3 and k is 0 or 1; and the derivatives thereof in which the hydrocarbon chain includes one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy. These compounds have biological activity, e.g. as anti-infective or anti-inflammatory agents.
摘要翻译: 本发明涉及以下通式的化合物:其中A是14-26个碳原子的饱和或不饱和烃链,B是(CH 2 CH 2) )其中n为0〜2的整数,m为0〜2的整数,n为0〜2的整数。 或通式(I),其中A'是9-26个碳原子的饱和或不饱和烃链,X是氧或不存在,B'是(CH 2 CH 2) 其中,j为1〜3的整数,k为0或1的化合物(COOH)k < 及其衍生物,其中烃链包括一个或多于一个选自羟基,氢过氧基,环氧基和过氧基的取代基。 这些化合物具有生物活性,例如 作为抗感染或抗炎剂。
-
公开(公告)号:US20050176815A1
公开(公告)日:2005-08-11
申请号:US11072195
申请日:2005-03-04
申请人: Antonio Ferrante , Christopher Easton , Ling Xia
发明人: Antonio Ferrante , Christopher Easton , Ling Xia
IPC分类号: A61K8/30 , A61K8/36 , A61K8/40 , A61K8/46 , A61K31/04 , A61K31/10 , A61K31/19 , A61K31/20 , A61K31/202 , A61K31/21 , A61K31/335 , A61P1/04 , A61P1/18 , A61P3/10 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/02 , A61P11/06 , A61P17/00 , A61P17/06 , A61P25/00 , A61P29/00 , A61P31/00 , A61P33/06 , A61P35/00 , A61P37/02 , A61P37/06 , A61P37/08 , A61P39/06 , A61P43/00 , C07C17/16 , C07C45/30 , C07C205/02 , C07C205/03 , C07C205/14 , C07C205/15 , C07C205/50 , C07C205/51 , C07C317/44 , C07C321/14 , C07C321/18 , C07C323/52 , C07C409/40 , A61K31/336 , C07C23/04
CPC分类号: C07C409/40 , A61K31/19 , A61K31/20 , A61K31/202 , A61K31/21 , A61K31/335 , A61K45/06 , C07C17/16 , C07C45/30 , C07C205/02 , C07C205/03 , C07C205/14 , C07C205/15 , C07C205/50 , C07C205/51 , C07C317/44 , C07C323/52 , Y02A50/411 , C07C19/075 , C07C21/14 , C07C47/02 , C07C47/21 , A61K2300/00
摘要: The present invention relates to compounds of the general formula: NO2-A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH2)n(COOH)m in which n is an integer from 0 to 2 and m is an integer from 0 to 2; or of general formula (I), wherein A′ is a saturated or unsaturated hydrocarbon chain of 9-26 carbon atoms, X is oxygen or is absent and B′ is (CH2)j(COOH)k in which j is an integer from 1 to 3 and k is 0 or 1; and the derivatives thereof in which the hydrocarbon chain includes one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy. These compounds have biological activity, e.g. as anti-infective or anti-inflammatory agents.
摘要翻译: 本发明涉及以下通式的化合物:其中A是14-26个碳原子的饱和或不饱和烃链,B是(CH 2 CH 2) )其中n为0〜2的整数,m为0〜2的整数,n为0〜2的整数。 或通式(I),其中A'是9-26个碳原子的饱和或不饱和烃链,X是氧或不存在,B'是(CH 2 CH 2) 其中,j为1〜3的整数,k为0或1的化合物(COOH)k < 及其衍生物,其中烃链包括一个或多于一个选自羟基,氢过氧基,环氧基和过氧基的取代基。 这些化合物具有生物活性,例如 作为抗感染或抗炎剂。
-
公开(公告)号:US20050176817A1
公开(公告)日:2005-08-11
申请号:US11072573
申请日:2005-03-04
申请人: Antonio Ferrante , Christopher Easton , Ling Xia
发明人: Antonio Ferrante , Christopher Easton , Ling Xia
IPC分类号: A61K8/30 , A61K8/36 , A61K8/40 , A61K8/46 , A61K31/04 , A61K31/10 , A61K31/19 , A61K31/20 , A61K31/202 , A61K31/21 , A61K31/335 , A61P1/04 , A61P1/18 , A61P3/10 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/02 , A61P11/06 , A61P17/00 , A61P17/06 , A61P25/00 , A61P29/00 , A61P31/00 , A61P33/06 , A61P35/00 , A61P37/02 , A61P37/06 , A61P37/08 , A61P39/06 , A61P43/00 , C07C17/16 , C07C45/30 , C07C205/02 , C07C205/03 , C07C205/14 , C07C205/15 , C07C205/50 , C07C205/51 , C07C317/44 , C07C321/14 , C07C321/18 , C07C323/52 , C07C409/40 , A61K31/336 , C07C23/04
CPC分类号: C07C409/40 , A61K31/19 , A61K31/20 , A61K31/202 , A61K31/21 , A61K31/335 , A61K45/06 , C07C17/16 , C07C45/30 , C07C205/02 , C07C205/03 , C07C205/14 , C07C205/15 , C07C205/50 , C07C205/51 , C07C317/44 , C07C323/52 , Y02A50/411 , C07C19/075 , C07C21/14 , C07C47/02 , C07C47/21 , A61K2300/00
摘要: The present invention relates to compounds of the general formula: NO2-A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH2)n(COOH)m in which n is an integer from 0 to 2 and m is an integer from 0 to 2; or of general formula (I), wherein A′ is a saturated or unsaturated hydrocarbon chain of 9-26 carbon atoms, X is oxygen or is absent and B′ is (CH2)j(COOH)k in which j is an integer from 1 to 3 and k is 0 or 1; and the derivatives thereof in which the hydrocarbon chain includes one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy. These compounds have biological activity, e.g. as anti-infective or anti-inflammatory agents.
摘要翻译: 本发明涉及以下通式的化合物:其中A是14-26个碳原子的饱和或不饱和烃链,B是(CH 2 CH 2) )其中n为0〜2的整数,m为0〜2的整数,n为0〜2的整数。 或通式(I),其中A'是9-26个碳原子的饱和或不饱和烃链,X是氧或不存在,B'是(CH 2 CH 2) 其中,j为1〜3的整数,k为0或1的化合物(COOH)k < 及其衍生物,其中烃链包括一个或多于一个选自羟基,氢过氧基,环氧基和过氧基的取代基。 这些化合物具有生物活性,例如 作为抗感染或抗炎剂。
-
公开(公告)号:US20050176816A1
公开(公告)日:2005-08-11
申请号:US11072389
申请日:2005-03-04
申请人: Antonio Ferrante , Christopher Easton , Ling Xia
发明人: Antonio Ferrante , Christopher Easton , Ling Xia
IPC分类号: A61K8/30 , A61K8/36 , A61K8/40 , A61K8/46 , A61K31/04 , A61K31/10 , A61K31/19 , A61K31/20 , A61K31/202 , A61K31/21 , A61K31/335 , A61P1/04 , A61P1/18 , A61P3/10 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/02 , A61P11/06 , A61P17/00 , A61P17/06 , A61P25/00 , A61P29/00 , A61P31/00 , A61P33/06 , A61P35/00 , A61P37/02 , A61P37/06 , A61P37/08 , A61P39/06 , A61P43/00 , C07C17/16 , C07C45/30 , C07C205/02 , C07C205/03 , C07C205/14 , C07C205/15 , C07C205/50 , C07C205/51 , C07C317/44 , C07C321/14 , C07C321/18 , C07C323/52 , C07C409/40 , A61K31/336 , C07C23/04
CPC分类号: C07C409/40 , A61K31/19 , A61K31/20 , A61K31/202 , A61K31/21 , A61K31/335 , A61K45/06 , C07C17/16 , C07C45/30 , C07C205/02 , C07C205/03 , C07C205/14 , C07C205/15 , C07C205/50 , C07C205/51 , C07C317/44 , C07C323/52 , Y02A50/411 , C07C19/075 , C07C21/14 , C07C47/02 , C07C47/21 , A61K2300/00
摘要: The present invention relates to compounds of the general formula: NO2-A-B wherein A is a saturated or unsaturated hydrocarbon chain of 14-26 carbon atoms and B is (CH2)n(COOH)m in which n is an integer from 0 to 2 and m is an integer from 0 to 2; or of general formula (I), wherein A′ is a saturated or unsaturated hydrocarbon chain of 9-26 carbon atoms, X is oxygen or is absent and B′ is (CH2)j(COOH)k in which j is an integer from 1 to 3 and k is 0 or 1; and the derivatives thereof in which the hydrocarbon chain includes one or more than one substitution selected from the group consisting of hydroxy, hydroperoxy, epoxy and peroxy. These compounds have biological activity, e.g. as anti-infective or anti-inflammatory agents.
摘要翻译: 本发明涉及以下通式的化合物:其中A是14-26个碳原子的饱和或不饱和烃链,B是(CH 2 CH 2) )其中n为0〜2的整数,m为0〜2的整数,n为0〜2的整数。 或通式(I),其中A'是9-26个碳原子的饱和或不饱和烃链,X是氧或不存在,B'是(CH 2 CH 2) 其中,j为1〜3的整数,k为0或1的化合物(COOH)k < 及其衍生物,其中烃链包括一个或多于一个选自羟基,氢过氧基,环氧基和过氧基的取代基。 这些化合物具有生物活性,例如 作为抗感染或抗炎剂。
-
公开(公告)号:US07030105B2
公开(公告)日:2006-04-18
申请号:US10430468
申请日:2003-05-06
申请人: Nicola E. Brasch , Ling Xia
发明人: Nicola E. Brasch , Ling Xia
IPC分类号: A61K31/40 , A61K31/155 , A61B5/055 , A61B10/00 , C07B47/00
CPC分类号: C07H23/00
摘要: The invention provides a method for preparing glutathionylcobalamin (GluSCbl) which involves running the reaction in an aqueous solvent with a relatively small excess of glutathione, i.e. GluSH, specifically from one to less than four molar equivalents of GluSH. The formed GluSCbl is precipitated from the aqueous solvent, preferably by the addition of a precipitate inducing solvent. This provides GluSCbl in acceptable purity without the need for an additional chromatographic purification step. Additionally, it has been found that the reaction can be run to an acceptable level of purity by using very high concentrations of the reactants, i.e. around saturation concentrations for aquocobalamin. This has the advantage of eliminating the need for air-free conditions.
摘要翻译: 本发明提供了一种制备谷胱甘肽钴胺素(GluSCbl)的方法,其包括在具有相对小量过量谷胱甘肽(即GluSH),特别是1至小于4摩尔当量的GluSH的水性溶剂中进行反应。 形成的GluSCb1从水性溶剂中沉淀出来,优选通过加入沉淀引发溶剂。 这提供了可接受纯度的GluSCbl,而不需要额外的色谱纯化步骤。 此外,已经发现,通过使用非常高浓度的反应物,即水溶胆固醇的饱和浓度,反应可以达到可接受的纯度水平。 这具有消除对无空气条件的需要的优点。
-
公开(公告)号:USD1000252S1
公开(公告)日:2023-10-03
申请号:US29798238
申请日:2021-07-07
申请人: Ling Xia
设计人: Ling Xia
摘要: FIG. 1 is a perspective view of a buckle showing my new design;
FIG. 2 is another perspective view thereof;
FIG. 3 is a front elevational view thereof;
FIG. 4 is a rear elevational view thereof;
FIG. 5 is a left side elevational view thereof;
FIG. 6 is a right side elevational view thereof;
FIG. 7 is a top plan view thereof; and,
FIG. 8 is a bottom plan view thereof.
The broken lines in the drawings depict portions of the buckle that form no part of the claimed design.
-
-
-
-
-